Eli Lilly and Co/ US5324571083 /
2024-05-02 10:10:00 PM | Chg. -20.84 | Volume | Bid12:40:20 AM | Ask12:40:20 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
755.91USD | -2.68% | 3.2 mill. Turnover: 1.38 bill. |
742.50Bid Size: 100 | 744.75Ask Size: 100 | 718.42 bill.USD | 0.62% | 129.88 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 5.82 USD | -16.02% |
EPS Diluted: | 5.80 USD | -15.94% |
Revenues per Share: | 35.91 USD | 19.58% |
Book Value per Share: | 11.43 USD | 0.83% |
Cash Flow per Share: | 4.46 USD | -40.14% |
Dividend per Share: | 4.69 USD | 15.23% |
Total | in mill. | |
Revenues: | 34,124.10 USD | 19.56% |
Net Income: | 5,240.40 USD | -16.08% |
Operating Cash Flow: | 4,240.10 USD | - |
Cash and Cash Equivalents: | 2,818.60 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 129.88 | 100.16 |
P/S Ratio: | 21.05 | 16.23 |
P/BV ratio: | 66.11 | 50.98 |
P/CF Ratio: | 169.39 | 130.63 |
PEG: | -8.11 | -6.25 |
Earnings Yield: | 0.77% | 1.00% |
Dividend Yield: | 0.62% | 0.80% |
Market Capitalization | ||
Market Capitalization: | 718.42 bill. USD | 553.87 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 950.16 mill. |
Profitability
Gross Profit Margin: | 79.25% |
EBIT Margin: | 0.00% |
Net Profit Margin: | 15.36% |
Return on Equity: | 48.24% |
Return on Assets: | 8.19% |
Financial Strength
Liquidity I / Cash Ratio: | 10.33% |
Liquidity II / Quick Ratio: | 51.86% |
Liquidity III / Current Ratio: | 94.26% |
Debt / Equity Ratio: | 489.18% |
Dynam. Debt / Equity Ratio: | 1,253.33% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | US GAAP |
Currency: | USD |